Humoral immune activation in amyotrophic lateral sclerosis patients

被引:9
|
作者
Rentzos, Michael [1 ]
Evangelopoulos, Maria Eleftheria [1 ]
Sereti, Eleni [2 ]
Zouvelou, Vassiliki [1 ]
Marmara, Styliani [2 ]
Alexakis, Theodoros [1 ]
Evdokimidis, Ioannis [1 ]
机构
[1] Athens Natl Univ, Aeginit Hosp, Sch Med, Dept Neurol, Athens, Greece
[2] Alexandra Hosp, Immunol Dept, Athens, Greece
关键词
IgM; IgG; IgA; amyotrophic lateral sclerosis; humoral immune activation;
D O I
10.4081/ni.2013.e3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
There is evidence that immunological factors may involved in the pathogenetic mechanisms of amyotrophic lateral sclerosis (ALS). Few studies to date have explored the status of the humoral immune response in patients with ALS. We examined the presence of humoral immune activation in ALS patients, serum immunoglobulins (IgG, IgA and IgM) levels were measured in 36 patients with ALS and 35 normal controls. Serum IgG, IgM and IgA levels were not significantly different in our ALS patients compared with the control group (P= ns). No correlations of serum IgG, IgM and IgA concentrations with duration, severity of the disease or the clinical form of onset (bulbar or spinal) were found in our ALS patients. Our results do not suggest a humoral immune activation in ALS patients. This does not exclude that immunological mechanisms may be involved in ALS pathogenesis.
引用
收藏
页码:8 / 9
页数:2
相关论文
共 50 条
  • [1] Evidence for peripheral immune activation in amyotrophic lateral sclerosis
    Chen, Xueping
    Feng, Weihua
    Huang, Rui
    Guo, Xiaoyan
    Chen, Yongping
    Zheng, Zhenzhen
    Shang, Huifang
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 347 (1-2) : 90 - 95
  • [2] Evaluation of Peripheral Immune Activation in Amyotrophic Lateral Sclerosis
    Wang, Mengli
    Liu, Zhen
    Du, Juan
    Yuan, Yanchun
    Jiao, Bin
    Zhang, Xuewei
    Hou, Xuan
    Shen, Lu
    Guo, Jifeng
    Jiang, Hong
    Xia, Kun
    Tang, Jianguang
    Zhang, Ruxu
    Tang, Beisha
    Wang, Junling
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [3] Immune system alterations in amyotrophic lateral sclerosis
    Hovden, H.
    Frederiksen, J. L.
    Pedersen, S. W.
    ACTA NEUROLOGICA SCANDINAVICA, 2013, 128 (05): : 287 - 296
  • [4] Management of patients with amyotrophic lateral sclerosis
    Pautex, S
    Janssens, JP
    Vuagnat, H
    Conne, P
    Zulian, GB
    SWISS MEDICAL WEEKLY, 2005, 135 (41-42) : 626 - 629
  • [5] Managing patients with amyotrophic lateral sclerosis
    Sathasivam, Sivakumar
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2009, 20 (04) : 355 - 358
  • [6] Neurorehabilitation in patients with amyotrophic lateral sclerosis
    Liska, D.
    Brunn, D.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2020, 83 (05) : 504 - 507
  • [7] Patients with amyotrophic lateral sclerosis and cancer do not differ clinically from patients with sporadic amyotrophic lateral sclerosis
    Vigliani, MC
    Polo, P
    Chiò, A
    Giometto, B
    Mazzini, L
    Schiffer, D
    JOURNAL OF NEUROLOGY, 2000, 247 (10) : 778 - 782
  • [8] Sleep in patients with amyotrophic lateral sclerosis
    Hetta, J
    Jansson, I
    JOURNAL OF NEUROLOGY, 1997, 244 (04) : S7 - S9
  • [9] Patients with amyotrophic lateral sclerosis and cancer do not differ clinically from patients with sporadic amyotrophic lateral sclerosis
    Maria Claudia Vigliani
    Patrizia Polo
    Adriano Chiò
    Bruno Giometto
    Letizia Mazzini
    Davide Schiffer
    Journal of Neurology, 2000, 247 : 778 - 782
  • [10] Golgi apparatus of the motor neurons in patients with amyotrophic lateral sclerosis and in mice models of amyotrophic lateral sclerosis
    Fujita, Y
    Okamoto, K
    NEUROPATHOLOGY, 2005, 25 (04) : 388 - 394